Royce & Associates LP Century Therapeutics, Inc. Transaction History

Royce & Associates LP

  • $10.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

May 23, 2023
BUY
$4.84 - $11.58 $55,321 - $132,359
11,430 New
11,430 $58,000
Q4 2022

Feb 13, 2023
BUY
$4.84 - $11.58 $55,321 - $132,359
11,430 New
11,430 $59,000
Q1 2022

May 05, 2022
SELL
$11.62 - $15.92 $149,898 - $205,368
-12,900 Closed
0 $0
Q4 2021

Feb 07, 2022
BUY
$13.93 - $23.62 $179,697 - $304,698
12,900 New
12,900 $205,000

Others Institutions Holding IPSC

# of Institutions
67
Shares Held
36.9M
Call Options Held
8.7K
Put Options Held
10.2K
View Full List

About Century Therapeutics, Inc.

IPSC Quotes by TradingView
  • Ticker IPSC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,881,800
  • Market Cap $74.2M
  • Description
  • Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...
More about IPSC
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email